Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.16 - $100.0 $20,056 - $12.5 Million
-125,350 Reduced 67.38%
60,688 $9,000
Q2 2022

Aug 15, 2022

SELL
$0.2 - $0.5 $25,709 - $64,273
-128,546 Reduced 40.86%
186,038 $77,000
Q1 2022

May 16, 2022

SELL
$0.41 - $0.63 $101,633 - $156,168
-247,886 Reduced 44.07%
314,584 $173,000
Q4 2021

Feb 14, 2022

SELL
$0.57 - $1.29 $34,180 - $77,354
-59,965 Reduced 9.63%
562,470 $328,000
Q3 2021

Nov 15, 2021

BUY
$1.11 - $1.7 $112,228 - $171,881
101,107 Added 19.39%
622,435 $766,000
Q2 2021

Aug 11, 2021

SELL
$1.46 - $2.25 $637,535 - $982,503
-436,668 Reduced 45.58%
521,328 $881,000
Q1 2021

May 17, 2021

BUY
$1.77 - $2.93 $1.01 Million - $1.67 Million
570,188 Added 147.03%
957,996 $1.72 Million
Q4 2020

Feb 16, 2021

BUY
$2.13 - $3.26 $793,322 - $1.21 Million
372,452 Added 2425.45%
387,808 $830,000
Q3 2020

Nov 16, 2020

SELL
$1.53 - $3.13 $157,886 - $322,997
-103,194 Reduced 87.05%
15,356 $46,000
Q2 2020

Aug 14, 2020

BUY
$0.48 - $1.75 $38,733 - $141,216
80,695 Added 213.17%
118,550 $178,000
Q1 2020

May 15, 2020

BUY
$0.56 - $0.97 $2,953 - $5,115
5,274 Added 16.19%
37,855 $21,000
Q4 2019

Feb 14, 2020

BUY
$0.62 - $1.06 $5,367 - $9,176
8,657 Added 36.19%
32,581 $27,000
Q3 2019

Nov 14, 2019

SELL
$0.81 - $1.06 $325,406 - $425,841
-401,737 Reduced 94.38%
23,924 $23,000
Q2 2019

Aug 16, 2019

BUY
$0.94 - $1.6 $77 - $131
82 Added 0.02%
425,661 $438,000
Q2 2019

Aug 14, 2019

BUY
$0.94 - $1.6 $205,173 - $349,232
218,270 Added 105.29%
425,579 $438,000
Q1 2019

May 15, 2019

BUY
$0.51 - $1.88 $105,727 - $389,740
207,309 New
207,309 $323,000
Q4 2018

Feb 14, 2019

SELL
$0.39 - $3.47 $97,559 - $868,027
-250,152 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$1.39 - $2.25 $242,677 - $392,823
174,588 Added 231.05%
250,152 $530,000
Q4 2017

Feb 14, 2018

BUY
$1.4 - $2.6 $221 - $410
158 Added 0.21%
75,564 $121,000
Q3 2017

Nov 20, 2017

BUY
$2.22 - $2.79 $167,401 - $210,382
75,406
75,406 $192,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.